DDXS News Alert Diadexus Inc (DDXS) 0.4300 02/14/2015 07:33:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Diadexus Inc (DDXS) 0.4300 $DDXS

Return To Growth Could Send Diadexus Shares Higher
Paul Nouri, CFP - Seeking Alpha - Thu Dec 25, 6:00AM CST
Diadexus (OTCQB: DDXS ) is a diagnostic company with a focus on cardiac diseases. Since going public in 2010, the company has grown sales from $12 million to $27 million in 2014. The company's primary test has been the FDA cleared PLAC ELISA test for...

FDA clears diaDexus CHD screening test
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 3:33PM CST


2014-2018 US Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers
M2 - Mon Dec 08, 8:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/vf9r39/20142018_us) has announced the addition of the "2014-2018 US Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Caliper - Cepheid - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Grifols - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/vf...0142018_us
MYGN: 34.03 (+0.40), A: 40.15 (+0.13), CPHD: 59.62 (+0.72), DHR: 86.81 (+0.21)

2014-2018 US Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers
M2 - Mon Dec 08, 8:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/mz6ptk/20142018_us) has announced the addition of the "2014-2018 US Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Company Profiles - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Orchid CellMark - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/mz...0142018_us
MYGN: 34.03 (+0.40), A: 40.15 (+0.13), DHR: 86.81 (+0.21)

Major Molecular Diagnostic Product Suppliers by Country 2014: Sales and Market Shares Analysis
M2 - Mon Oct 06, 6:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mbs9pk/sales_and_market) has announced the addition of the "Sales and Market Shares of Major Molecular Diagnostic Product Suppliers by Country" report to their offering. This unique report provides sales and market share estimates for major suppliers of molecular diagnostic products by country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Cepheid - Decode - Diadexus - Eiken - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Orchid CellMark - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio For more information visit http://www.researchandmarkets.com/research/mb...and_market
MYGN: 34.03 (+0.40), DHR: 86.81 (+0.21), SQNM: 3.62 (unch), CPHD: 59.62 (+0.72), HOLX: 30.46 (+0.21)

UK Major Molecular Diagnostic Product Suppliers Sales and Market Shares 2014
M2 - Mon Oct 06, 6:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lgmvkt/uk_sales_and) has announced the addition of the "UK Sales and Market Shares of Major Molecular Diagnostic Product Suppliers" report to their offering. This unique report provides UK sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio For more information visit http://www.researchandmarkets.com/research/lg..._sales_and
MYGN: 34.03 (+0.40), A: 40.15 (+0.13), DHR: 86.81 (+0.21), SQNM: 3.62 (unch), HOLX: 30.46 (+0.21)

Italy Major Molecular Diagnostic Product Suppliers Sales and Market Shares 2014
M2 - Mon Oct 06, 6:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zw7xts/italy_sales_and) has announced the addition of the "Italy Sales and Market Shares of Major Molecular Diagnostic Product Suppliers" report to their offering. This unique report provides Italy sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio For more information visit http://www.researchandmarkets.com/research/zw..._sales_and
MYGN: 34.03 (+0.40), A: 40.15 (+0.13), DHR: 86.81 (+0.21), SQNM: 3.62 (unch), HOLX: 30.46 (+0.21)

European Major Molecular Diagnostic Product Suppliers Sales and Market Shares 2014
M2 - Mon Oct 06, 6:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cw28k8/europe_sales_and) has announced the addition of the "Europe Sales and Market Shares of Major Molecular Diagnostic Product Suppliers by Country" report to their offering. This unique report provides Europe sales and market share estimates for major suppliers of molecular diagnostic products by country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Decode - Diadexus - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/cw..._sales_and
SQNM: 3.62 (unch), MYGN: 34.03 (+0.40), A: 40.15 (+0.13), DHR: 86.81 (+0.21), HOLX: 30.46 (+0.21)

Germany Major Molecular Diagnostic Product Suppliers Report 2014 - Sales and Market Shares Analysis
M2 - Mon Oct 06, 6:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d86mxx/germany_sales_and) has announced the addition of the "Germany Sales and Market Shares of Major Molecular Diagnostic Product Suppliers" report to their offering. This unique report provides Germany sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Cepheid - Diadexus - Enzo - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Siemens - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/d8..._sales_and
MYGN: 34.03 (+0.40), A: 40.15 (+0.13), DHR: 86.81 (+0.21), CPHD: 59.62 (+0.72), HOLX: 30.46 (+0.21)

France Major Molecular Diagnostic Product Suppliers Sales and Market Shares 2014
M2 - Mon Oct 06, 5:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rdwfqz/france_sales_and) has announced the addition of the "France Sales and Market Shares of Major Molecular Diagnostic Product Suppliers" report to their offering. This unique report provides France sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Caliper - Cepheid - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Orchid CellMark - Ortho-Clinical Diagnostics For more information visit http://www.researchandmarkets.com/research/rd..._sales_and
MYGN: 34.03 (+0.40), A: 40.15 (+0.13), CPHD: 59.62 (+0.72), DHR: 86.81 (+0.21), HOLX: 30.46 (+0.21)

Spain Major Molecular Diagnostic Product Suppliers Sales and Market Shares 2014
M2 - Fri Oct 03, 9:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2vmh7b/spain_sales_and) has announced the addition of the "Spain Sales and Market Shares of Major Molecular Diagnostic Product Suppliers" report to their offering. This unique report provides Spain sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Caliper - Cepheid - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Orchid CellMark - Ortho-Clinical Diagnostics For more information visit http://www.researchandmarkets.com/research/2v..._sales_and
MYGN: 34.03 (+0.40), A: 40.15 (+0.13), CPHD: 59.62 (+0.72), DHR: 86.81 (+0.21), HOLX: 30.46 (+0.21)

2014 UK Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country
M2 - Thu Oct 02, 5:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vjh39d/uk_sales_and) has announced the addition of the "UK Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country" report to their offering. This unique report provides UK sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. List of Tables - U.K., Total Tumor Marker Sales by Major Supplier - U.K., CEA Testing Market Diagnostics - Sales by Major Supplier - U.K., PSA Testing Market Diagnostics - Sales by Major Supplier Companies Mentioned: - Abbott - AdnaGen - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics - bioMerieux - Bio-Rad - Correlogic Systems/Vermillion - Decode - Diadexus - Diagnocure - Diasorin - Eiken Chemical - Epigenomics - Enterix - Enzo Biochem - Quest Diagnostics - Radient Pharmaceuticals - Roche - Siemens Healthcare - Takara Bio - Thermo Fisher/Life Technologies - Tosoh - Veridex - Wako Pure Chemicals - Wallac/PE - Zila For more information visit http://www.researchandmarkets.com/research/vj..._sales_and
ENZ: 3.12 (-0.18), A: 40.15 (+0.13), DGX: 71.68 (+0.03), DHR: 86.81 (+0.21)

US Sales and Market Shares of Major Molecular Diagnostic Product Suppliers 2014
M2 - Wed Oct 01, 6:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/26zf2b/us_sales_and) has announced the addition of the "US Sales and Market Shares of Major Molecular Diagnostic Product Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Caliper - Cepheid - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Orchid CellMark - Ortho-Clinical Diagnostics For more information visit http://www.researchandmarkets.com/research/26..._sales_and
MYGN: 34.03 (+0.40), A: 40.15 (+0.13), CPHD: 59.62 (+0.72), DHR: 86.81 (+0.21), HOLX: 30.46 (+0.21)

Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country
M2 - Tue Sep 30, 5:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mwszsk/sales_and_market) has announced the addition of the "Sales and Market Shares of Major Cancer Diagnostic Testing Product Suppliers by Assay and Country" report to their offering. This new report provides sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Companies Featured (Partial List) - Abbott - AdnaGen - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics - bioMerieux - Bio-Rad - CellSearch - Cepheid - Correlogic Systems/Vermillion - Decode - Diadexus - Diagnocure - DiaSorin - Eiken Chemical - Epigenomics - Enterix - Enzo Biochem - Exact Sciences - Fujirebio/Innogenetics - Guided Therapeutics - Hologic/Gen-Probe - Kreatech - Kyowa Medex - Mackay Life Sciences - Myriad Genetics - Nanogen Elitech For more information visit http://www.researchandmarkets.com/research/mw...and_market
MYGN: 34.03 (+0.40), ENZ: 3.12 (-0.18), A: 40.15 (+0.13), CPHD: 59.62 (+0.72), DHR: 86.81 (+0.21), HOLX: 30.46 (+0.21)

diaDexus announces changes in executive roles
M2 - Tue Sep 23, 6:59AM CDT
Diagnostic products company diaDexus (Other OTC DXS) reported on Monday the addition of Dr. Kenneth C. Fang, M.D. as its chief medical officer.

diaDexus reports planned resignation of CFO Jean Viret
M2 - Wed Sep 10, 6:37AM CDT
Cardiovascular diagnostic company diaDexus (Other OTC DXS) revealed on Tuesday that Dr Jean Viret, PhD plans to step down as its chief financial officer with effect from 19 September 2014.

US Infectious Disease Molecular Diagnostics Market - Supplier Shares, Emerging Technologies & Competitive Landscape
M2 - Thu Aug 28, 5:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cp27n9/us_infectious) has announced the addition of the "US Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape" report to their offering. This new study contains 636 pages, 27 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. U.S. Market Overview: - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by market segment. - Five-year test volume and sales projections. Market Segmentation Analysis: - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers. Product/Technology Review: - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Opportunities and Strategic Recommendations: - Specific new product development opportunities with potentially significant market appeal during the next five years. - Design criteria for new products. - Alternative market penetration strategies. - Potential market entry barriers and risks. - Business planning issues and concerns. Competitive Profiles - Abbott - Affymetrix - Agilent Technologies - Beckman Coulter/Danaher - Becton Dickinson - BioMerieux - Bio-Rad - Caliper - Cepheid - Decode - Diadexus - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Qiagen - Roche - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/cp...infectious
MYGN: 34.03 (+0.40), A: 40.15 (+0.13), DHR: 86.81 (+0.21), SQNM: 3.62 (unch), CPHD: 59.62 (+0.72), HOLX: 30.46 (+0.21)

diaDexus enters into USD15m debt financing agreement with Oxford Finance
M2 - Tue Aug 19, 10:59AM CDT
Cardiovascular diagnostic company diaDexus (Other OTC DXS) reported on Monday the execution of a USD15m senior secured term loan with Oxford Finance.

diaDexus, Inc. Secures $15 Million Debt Financing
Business Wire - Mon Aug 18, 7:30AM CDT
diaDexus, Inc. (OTCQB DXS), a commercial stage developer of proprietary cardiovascular diagnostic products, today announced it has entered into a $15 million senior secured term loan with Oxford Finance. The Company will use the funding to refinance its existing $8.1 million debt from Comerica and advance the company's development and commercialization of additional diagnostic testing solutions.
CMA: 46.42 (-0.10)

diaDexus' PLAC Test for Lp-PLA2 Activity accepted for US FDA's review
M2 - Fri Jul 18, 9:52AM CDT
Diagnostic company diaDexus (Other OTC DXS) stated on Thursday that the traditional 510(k) submission of the PLAC Test for Lp-PLA2 Activity was found to contain all of the necessary information needed to proceed with the substantive review by the US Food and Drug Administration.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ensurge Micropower ASA Expands Share Capital for Growth

Updated Category News Views 226

Ensurge Micropower ASA Expands Share Capital for Future Development Recently, Ensurge Micropower ASA made a significant announcement regarding a successful private placement of shares that was fully underwritten. This move is a key step in enhancing the company's financial foundation and preparing for future growth. Successful Registration of Share Capital Increase The...

Continue Reading
Power Solutions International Faces Securities Fraud Investigation

Updated Category News Views 287

Understanding the Investigation Against Power Solutions International Power Solutions International, Inc. (NASDAQ: PSIX), known for its innovative power generation solutions, is currently facing an investigation related to possible violations of federal securities laws. This inquiry has been initiated to protect investors who may have suffered financial losses due to the...

Continue Reading
Point-of-Care Testing Market Set for US$64.8B Boom by 2031

Updated Category News Views 8

Market Poised for Rapid Growth Surfs up for the point-of-care testing (POCT) market, as fresh numbers just dropped and they're flashy, aiming for a jump from $42 billion in 2025 to nearly $64.8 billion by 2031. That’s a solid 7.5% CAGR for anyone counting. These days, quick-and-dirty diagnostics are what folks in the medical field are pinning their hopes on to keep pace...

Continue Reading
Understanding First Solar's Options Market Trends

Updated Category News Views 119

Market Movements of First Solar Recent trading activity has shown significant movements in the options market for First Solar (NASDAQ: FSLR). Financial institutions and traders alike have exhibited clear bearish sentiments this quarter. Our evaluation of recent options data indicates that there were 21 unusual trades for First Solar in recent sessions. Analysis of Trader...

Continue Reading
Bloomin' Brands Faces Profitability Challenges and Outlook Cut

Updated Category News Views 213

Overview of Bloomin' Brands, Inc. Bloomin’ Brands, Inc. (NASDAQ: BLMN), a leader in the casual dining sector, is currently navigating turbulent waters as its stock experiences a significant downturn. The company's shares have recently dropped substantially, reflecting concerns over profitability amidst rising operating expenses. Strong Earnings Yet Declining Margins In...

Continue Reading